Optofluidics, Inc.

Biotechnology company · Burlingame, California, United States

Optofluidics, Inc. is a biotechnology company headquartered in Burlingame, California, United States. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $2.9 million in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2022.

opfluid.comProfile compiled from public records. Is this your company? Request a correction or update

Optofluidics at a glance

Typebiotechnology company
HeadquartersBurlingame, California, United States
Employees (self-reported, 2018)7
SEC CIK1762996

What does Optofluidics do?

US government research funding

5 SBIR/STTR small-business research awards from US health agencies, $2.9 million in total (2013 to 2018). NIH funding came from the FDA, National Institute of General Medical Sciences.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $7 million sold (2022).

Frequently asked questions about Optofluidics

Where is Optofluidics headquartered?

Optofluidics, Inc. is headquartered in Burlingame, California, United States.

What does Optofluidics do?

Optofluidics, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences